Rudack et al., showed that after protease-activated receptor-2 (PAR-2) stimulation, the CXCL1 and CXCL8 can be synthesized by activating nuclear factor-kappa B (NF-κB) signaling in their CRS study [7]. The gene discussed is F2RL1; the disease is congenital rubella syndrome.